Agios Pharmaceuticals (MEX:AGIO) Inventories, Work In Process: MXN0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:AGIO Agios Pharmaceuticals Inc MEX:AGIO
47 GF Score
Price MXN1,222.00
GF Value MXN4,075.15
! 3 Warning Signs
View Full Analysis

What is Agios Pharmaceuticals Inventories, Work In Process?

Agios Pharmaceuticals MEX:AGIO 47 Inventories, Work In Process is MXN0 Mil as of Jun. 2026. GuruFocus rates MEX:AGIO with a GF Score™ of 47/100 and a GF Value™ of MXN4,075.15. The stock has 3 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Agios Pharmaceuticals's work in process for the quarter that ended in Jun. 2026 was MXN0 Mil.

Agios Pharmaceuticals Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Agios Pharmaceuticals's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agios Pharmaceuticals Inventories, Work In Process Chart

Agios Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 147.20 298.20 511.15 544.73

Agios Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 512.29 538.59 544.73 560.49 0.00
MEX:AGIO
47GF Score
Agios Pharmaceuticals Inc MEX:AGIO
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agios Pharmaceuticals Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of MXN0 Mil mean?
Agios Pharmaceuticals (MEX:AGIO) has a Inventories, Work In Process of MXN0 Mil as of Jun. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Agios Pharmaceuticals and its competitors.
Is Agios Pharmaceuticals' Inventories, Work In Process too high?
Agios Pharmaceuticals' current Inventories, Work In Process is MXN0 Mil. Overall, Agios Pharmaceuticals has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Agios Pharmaceuticals' Inventories, Work In Process compare to BHVN and VRDN?
Agios Pharmaceuticals' Inventories, Work In Process of MXN0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Agios Pharmaceuticals and its competitors. Agios Pharmaceuticals's current Inventories, Work In Process is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agios Pharmaceuticals stock overvalued right now?
Agios Pharmaceuticals (MEX:AGIO) has a current Inventories, Work In Process of MXN0 Mil. The stock's GF Value™ is MXN4,075.15, compared to a current price of MXN1,222.00 — trading 70% below its estimated fair value. The current Inventories, Work In Process is MXN0 Mil. Agios Pharmaceuticals' overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Agios Pharmaceuticals (MEX:AGIO), the current Inventories, Work In Process is MXN0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agios Pharmaceuticals (MEX:AGIO) Overvalued in 2026?

Based on GuruFocus' analysis, Agios Pharmaceuticals stock appears to be undervalued. The current stock price of MXN1,222.00 is trading 70% below its estimated GF Value™ of MXN4,075.15.

Key valuation signals for MEX:AGIO:

  • Inventories, Work In Process: MXN0 Mil
  • GF Value™: MXN4,075.15 vs. price of MXN1,222.00 (70% below fair value)
  • GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the MEX:AGIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Agios Pharmaceuticals Business Description

Other Exchanges AGIO:USA0HB0:UK8AP:Germany
Address 88 Sidney Street, Cambridge, MA, USA, 02139
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
47GF Score

Get the complete analysis for MEX:AGIO

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,222.00
Price
MXN4,075.15
GF Value